Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

RARE PHOTOS: 2 | Rare Historical Photos

Does Medicare pay for dementia care? Here's what coverage you can expect for treatments and therapies

Medicare and Medicare Advantage provide some coverage for dementia, beginning with the diagnosis.

Fortune

Finding Alzheimer’s Support in the Black Church

South Los Angeles churches invite doctors, researchers and government representatives to bring help to those who need it.

Capital & Main

Should You Be Able To Take an Alzheimer's Test at Home?

Plus, an AI-generated version of the same article

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

Los Angeles’ Black Churches Join National Effort to Support Dementia Patients and Their Families

South L.A. churches craft dementia-friendly services aimed at providing solace to a community disproportionately affected by the disease.

Capital & Main

Breakthroughs in Alzheimer’s Research Give Cause for Optimism

Advances in Alzheimer’s research raise hopes of preventing and someday curing the senior plague.

Kiplinger

Promising Blood Test Shows Early Alzheimer's Detection Potential

A new study suggests a promising blood test that could diagnose Alzheimer's disease accurately and early, potentially revolutionizing dementia care.

Top News

The Holidays Are a Time for Sharing (Your Wishes)

While cognitive decline isn’t the most festive topic to bring up during a holiday get-together, getting the conversation started now can ensure everything is in place if, or when, something happens.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Alzheimer's Disease Disproportionately Affects Hispanics Due to Language Barriers and Stigma

Border counties in Texas have some of the highest Alzheimer's diagnosis rates in the nation

Latin Times

Stigma and language barriers complicate treating Hispanics with Alzheimer’s disease

Border counties in Texas have some of the highest Alzheimer’s diagnosis rates in the nation, with rates ranging from 13% to 18% of people aged 65 and over.

The Texas Tribune

What biomarkers say about Alzheimer's

There's still no established cause for Alzheimer's, but emphasizing some symptoms can have unintended consequences

Salon

Do new Alzheimer's drugs actually help?

Fast-track approval of three risky drugs intends to slow the disease, but evidence they benefit patients is shaky

Salon

Will you develop dementia? These 11 factors are strong predictors in middle-age, scientists say

The good news: You can reduce your risk for four of them.

Fortune

Study: Baltimore ranks among jurisdictions with highest Alzheimer’s disease prevalence

Baltimore has one of the highest rates of Alzheimer’s disease in the country and Maryland has the highest rate among states, according to an analysis published in the Alzheimer’s Association’s online journal.

Tribune News Service

Alzheimer’s rates highest in Texas border counties, new study shows

Texas’ border counties have higher rates of Alzheimer’s disease among older adults than other areas in the state, according to a new study estimating county-level prevalence of the neurodegenerative disease.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

‘He didn’t need to go to jail’: Dementia experts fear more run-ins with police as condition becomes more prevalent

BALTIMORE -- Samantha Hart hardly recognized her father when she picked him up at the Baltimore County jail.

Axios

FDA approves Leqembi, first drug to slow Alzheimer’s progression

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

Roll Call

Expected Alzheimer’s drug approval signals new era in treatment - Roll Call

The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

Fortune

Does Medicare pay for Alzheimer's drugs? The answer is complicated and changing

There are no drugs or treatments to cure Alzheimer’s disease, but emerging drugs may slow disease progression.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

FDA advisers say new Alzheimer’s drug lecanemab slows cognitive decline

Panel’s opinion could pave way for full regulatory approval next month for treatment of disease that affects 6.5m Americans

Daily Mirror

Experts' warning over common disorders that could actually be signs of dementia

Depression, sleep apnea and vitamin deficiency are just some of the disorders known as 'dementia mimickers' - illnesses that have symptoms very similar to dementia's

Nottingham Post

Dementia experts share tell-tale signs of disease as one labels disease 'time bomb' for ageing population

The awful disease, which can see patients forgetting their dearest family members, affects more than 850,000 people in the UK according to the NHS

Daily Record

Dementia experts reveal tell-tale signs of disease amid 'time bomb' population warning

Researchers say that improved life expectancy is leading to a rise in the number of people with Alzheimer's or another form of the disease.

Daily Mirror

Dementia experts reveal tell-tale signs of disease as one warns disease is 'time bomb' in US population

Over one in 10 adults in the US over the age of 65 have dementia. Although most patients have Alzheimer's there are other less common types including Frontotemporal dementia which Hollywood star Bruce Willis has been diagnosed with

The Independent UK

A daily multivitamin to boost memory? Here's what to know

A new study shows a daily multivitamin may boost memory function in some people, although the results don't change recommendations about use of the supplements

Chicago Tribune

Commentary: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

the University of Chicago

the Alzheimer Society

59 stories

Texas State University

55 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.